back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-11 12:46 Tx date 2026-06-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Islam, Khalid
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$217,499
+25,000 vol $8.70 each |
250,000 | |
| Filed 2026-06-11 12:45 Tx date 2026-06-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,000
+20,000 vol $8.70 each |
232,229 | |
| Filed 2026-06-11 12:42 Tx date 2026-06-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Brughera, Marco
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,000
+20,000 vol $8.70 each |
235,545 | |
| Filed 2026-06-11 12:39 Tx date 2026-06-10 |
$FRX
Fennec Pharmaceuticals Inc. |
Jodi, Cook
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,000
+20,000 vol $8.70 each |
160,000 | |
| Filed 2026-06-04 13:09 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Sayad, Pierre
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+168 vol |
21,015 | |
| Filed 2026-06-04 13:08 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-93,766.14
-9,747 vol $9.62 each |
2,746,104 | |
| Filed 2026-06-04 13:07 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,212
+15,597 vol $2.45 each |
2,755,851 | |
| Filed 2026-06-04 13:06 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-38,212.65
-15,597 vol $2.45 each |
21,420,456 | |
| Filed 2026-06-04 13:04 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,778 vol |
2,740,254 | |
| Filed 2026-06-04 13:03 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Hackman, Jeffrey
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,159 vol |
62,825 | |
| Filed 2026-06-04 13:01 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Evans, Terry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+168 vol |
21,015 | |
| Filed 2026-06-04 12:59 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Cioffi, Christiana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+156 vol |
24,176 | |
| Filed 2026-06-04 12:56 Tx date 2026-06-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,703 vol |
321,113 | |
| Filed 2026-05-11 17:07 Tx date 2026-05-11 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-58,839.30
-8,346 vol $7.05 each |
61,314 | |
| Filed 2026-05-11 17:06 Tx date 2026-05-11 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$34,999
+14,344 vol $2.44 each |
69,660 | |
| Filed 2026-05-11 17:06 Tx date 2026-05-11 |
$FRX
Fennec Pharmaceuticals Inc. |
Rallis, Chris Anigeron
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-34,999.36
-14,344 vol $2.44 each |
212,229 | |
| Filed 2026-05-05 11:31 Tx date 2026-05-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+2,778 vol |
2,737,476 | |
| Filed 2026-05-05 11:30 Tx date 2026-05-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-69,753.07
-10,781 vol $6.47 each |
2,734,698 | |
| Filed 2026-05-05 11:30 Tx date 2026-05-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,215
+15,598 vol $2.45 each |
2,745,479 | |
| Filed 2026-05-05 11:29 Tx date 2026-05-01 |
$FRX
Fennec Pharmaceuticals Inc. |
Raykov, Rostislav Christov
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-38,215.10
-15,598 vol $2.45 each |
21,436,053 |